Halper Sadeh LLC Investigates CRNX, ESI, INVE, SLP Deals for Shareholder Fairness

GlobeNewswire··Read original
2▲0 ▼0Impact / 5
Summary · why it matters

Halper Sadeh LLC, an investor rights law firm, is investigating whether the proposed sales of Crinetics Pharmaceuticals, Element Solutions, Identiv, and Simulations Plus are obtaining fair deals for their shareholders. The firm is examining Crinetics Pharmaceuticals' sale to Vertex Pharmaceuticals for $85.00 per share in cash, Element Solutions' sale to Solstice Advanced Materials for $10.00 in cash and 0.500 shares of Solstice common stock per Element share, Identiv's sale of its IoT business operating assets and Thai subsidiary to Trackonomy Systems, and Simulations Plus' sale to affiliates of Altaris for $18.50 per share. Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief on behalf of shareholders, and encourages affected investors to contact the firm to discuss their legal rights and options at no cost.

Impact on assets 6

Biotech & Genomic Medicine▲
Crinetics Pharmaceuticals Inc
CRNX
± MixedCapitalrelevance

Investigation into whether the sale to Vertex at $85/share is fair; may seek increased consideration or additional disclosures.

Simulations Plus Inc
SLP
± MixedCapitalrelevance

Investigation into whether the sale to Altaris affiliates at $18.50/share is fair; may seek increased consideration or additional disclosures.

Semiconductors▲
Element Solutions Inc
ESI
± MixedCapitalrelevance

Investigation into whether the sale to Solstice Advanced Materials is fair; may seek increased consideration or additional disclosures.

Smart City / Autonomous Infrastructure▲
Identiv Inc
INVE
± MixedCapitalrelevance

Investigation into whether the sale of IoT business and Thai subsidiary to Trackonomy is fair; may seek increased consideration or additional disclosures.

Critical Materials & Supply Chain▲

Off-coverage companies 2

Altaris Capital Partnersi
Private± Mixedrelevance

Trackonomy Systemsi
Private± Mixedrelevance